Evidence map›Paper›PMID 32889019›Full record

ArticleInternational journal of cardiology2021

Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb.

Amélie Cransac-Miet, Marianne Zeller, Frédéric Chagué, Agnès Soudry Faure, Florence Bichat, Nicolas Danchin, Mathieu Boulin, Yves Cottin

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Amélie Cransac-MietPharmacy Department, University Hospital, Dijon, France; LNC UMR 1231, University Hospital, Dijon, France.
Marianne ZellerPEC2, EA 7460 Dijon, France.
Frédéric ChaguéCardiology Department, University Hospital, Dijon, France.
Agnès Soudry FaureDepartment of Clinical Research and Investigation, University Hospital, Dijon, France.
Florence BichatCardiology Department, University Hospital, Dijon, France.
Nicolas DanchinCardiology Department, European Hospital Georges Pompidou, Paris, France.
Mathieu BoulinPharmacy Department, University Hospital, Dijon, France; LNC UMR 1231, University Hospital, Dijon, France.
Yves CottinCardiology Department, University Hospital, Dijon, France. Electronic address: yves.cottin@chu-dijon.fr.
CHU Dijon Bourgogne · FRMaison des Sciences sociales et des Humanités de Dijon · FRCentre de recherche Translationnelle en Médecine moléculaire · FRHôpital Européen · FRPhysiopathologie et Epidémiologie Cérébro-Cardiovasculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to evaluate the impact of coronavirus disease 2019 (COVID-19)-related lockdown on adherence to lifestyle and drug regimens in stay-at-home chronic coronary syndromes patients living in urban and rural areas.

methodsA cross-sectional population-based study was perfomed in patients with chronic coronary syndromes. A sample of 205 patients was randomly drawn from the RICO (Observatoire des infarctus de Côte d'Or) cohort. Eight trained interviewers collected data by phone interview during week 16 (April 13 to April 19), i.e. 4 weeks after implementation of the French lockdown (start March 17, 2020).

resultsAmong the 195 patients interviewed (of the 205, 3 had died, 1 declined, 6 lost), mean age was 65.5 ± 11.1 years. Only six patients (3%) reported drug discontinuation, mainly driven by media influence or family members. All 166 (85%) patients taking aspirin continued their prescribed daily intake. Lifestyle rules were less respected since almost half (45%) declared >25% reduction in physical activity, 26% of smokers increased their tobacco consumption by >25%, and 24% of patients increased their body weight > 2 kg. The decrease in physical activity and the increase in smoking were significantly greater in urban patients (P < .05).

conclusionsThe COVID-19-related lockdown had a negative impact on lifestyle in a representative sample of stay-at-home CCS patients.

Indexed as

Health BehaviorLife StyleAgedCardiovascular DiseasesChronic DiseaseCOVID-19Cross-Sectional StudiesDrug MonitoringExerciseFemaleFranceHumansMaleQuarantineRural PopulationSmokingAdherenceChronic coronary syndromesCOVID-19LifestyleLockdown

Identifiers

PMID32889019
PMCPMC7462445
OpenAlexW3082569938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.